Autres langues Oramed Pharmaceuticals Inc. Deutsche Boerse AG

Actions

OJU1

US68403P2039

Recherche biotechnologique et médicale

Temps réel estimé Tradegate 16:23:52 10/09/2026			Varia. 5j.	Varia. 1 janv.
4,078 ^EUR	-3,36%		-5,82%	+67,70%

31/08	Lifeward nomme Josh Hexter au poste de PDG par intérim et Rami Aviram à la direction financière	MT
10/08	Oramed Pharmaceuticals Inc. publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI

Autres langues

31/08	Lifeward Names Josh Hexter as Interim CEO and Rami Aviram as CFO
10/08	Oramed: Q2 Earnings Snapshot
10/08	Oramed Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
08/07	Lifeward Ltd. announced that it has received $11.16 million in funding from Oramed Pharmaceuticals Inc.
30/06	Lifeward Ltd. announced that it expects to receive $11.16 million in funding from Oramed Pharmaceuticals Inc.
29/06	Oramed Pharmaceuticals Inc.(NasdaqCM:ORMP) added to Russell 2000 Index
29/06	Oramed Pharmaceuticals Inc.(NasdaqCM:ORMP) added to Russell 2000 Value Benchmark
29/06	Oramed Pharmaceuticals Inc.(NasdaqCM:ORMP) added to Russell 3000E Index
29/06	Oramed Pharmaceuticals Inc.(NasdaqCM:ORMP) added to Russell 2000 Value-Defensive Index
29/06	Oramed Pharmaceuticals Inc.(NasdaqCM:ORMP) added to Russell 3000E Value Benchmark
29/06	Oramed Pharmaceuticals Inc.(NasdaqCM:ORMP) added to Russell 2000 Dynamic Index
29/06	Oramed Pharmaceuticals Inc.(NasdaqCM:ORMP) added to Russell 2000 Defensive Index
29/06	Oramed Pharmaceuticals Inc.(NasdaqCM:ORMP) added to Russell 3000 Value Benchmark
29/06	Oramed Pharmaceuticals Inc.(NasdaqCM:ORMP) added to Russell Small Cap Completeness Index
29/06	Oramed Pharmaceuticals Inc.(NasdaqCM:ORMP) added to Russell 2500 Index
29/06	Oramed Pharmaceuticals Inc.(NasdaqCM:ORMP) added to Russell Small Cap Comp Value Benchmark
29/06	Oramed Pharmaceuticals Inc.(NasdaqCM:ORMP) added to Russell 2500 Value Benchmark
29/06	Oramed Pharmaceuticals Inc.(NasdaqCM:ORMP) added to Russell 3000 Index
25/06	Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan Repayment, Strategic Portfolio Appreciation, and a Strengthened Balance Sheet
17/06	Oramed Pharmaceuticals to Join Russell 2000® and Russell 3000® Indexes
19/05	Oramed: Q1 Earnings Snapshot
19/05	Oramed Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026
26/03	Oramed: Q4 Earnings Snapshot
26/03	Tranche Update on Oramed Pharmaceuticals Inc.'s Equity Buyback Plan announced on June 26, 2024.
26/03	Oramed Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2025